Rinsy Rahman

Rinsy Rahman

Auto-generated profile, based on publicly available information

Rinsy Rahman

Department of Health Information Management, Manipal College of Health Professions Manipal Karnataka 576104 Manipal Academy of Higher Education

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2023 in Hypertension
Verified
Journal Article
Closed access
SMShruti Murthy
Shruti Murthy
EREti Rajwar
Eti Rajwar
RJRosemol Johnson
Rosemol Johnson
KSKrati Shrivastava
Krati Shrivastava
PKPrashanthi Kamath
Prashanthi Kamath
OJOommen John
Oommen John
Background: To identify and summarize the global research literature on validation of automated noninvasive blood pressure measurement devices (BPMDs) with upper arm cuff, develop a repository of validated BPMDs in compliance with the 2020 World Health Organization technical specifications, and identify challenges and gaps in evidence base on validated BPMDs. Methods: A scoping review was conducted. Primary research validating BPMDs complying with the 2020 World Health Organization technical specifications (ie, semiautomated/automated noninvasive devices with upper arm cuff), published in English between January 2000 and December 2021, was included. We searched MEDLINE, Web of Science, Scopus, EMBASE, CINAHL, CENTRAL, ProQuest and the dabl website. Results: We included 269 studies validating 251 BPMDs across 89 manufacturers. Omron (29%), Microlife (10%), and A&D Company (8%) were the top 3 manufacturers. The 3 most frequently used validation protocols were the European Society of Hypertension-international protocol 2002 (27%), European Society of Hypertension-international protocol 2010 (25%), and modified British Hypertension Society protocol 1993 (16%), respectively. Nearly 45% of the validated BPMDs were intended for use in clinical settings, 38% were for home or self-measurement use, and 48% were for general adults. Most studies reported that BPMDs passed the validation criteria. There was inadequate reporting across studies, especially pertaining to validation settings. Conclusions: Most BPMDs fulfilled the validation criteria. However, there are considerable gaps in BPMD research in terms of geographical representation, including specific target populations and diseases/conditions, and a range of arm circumferences. Additionally, a potential strategy is required to accelerate the adoption of the Association for the Advancement of Medical Instrumentation (AAMI)/European Society of Hypertension/International Organization for Standardization Universal Standard (International Organization for Standardization 81060-2:2018) for BPMD validation.

5 February 2025 in F1000Research
Verified
Journal Article
Open access
PDF file
RRRinsy Rahman
Rinsy Rahman
DSDola Saha
Dola Saha
WDWinniecia Dkhar
Winniecia Dkhar
SMSathyendranath Malli
Sathyendranath Malli
NANeil Barnes Abraham
Neil Barnes Abraham
Background Breast cancer remains a significant global health concern, with over 7.8 million cases reported in the last five years. Early detection and accurate classification are crucial for reducing mortality rates and improving outcomes. Machine learning (ML) has emerged as a transformative tool in medical imaging, enabling more efficient and accurate diagnostic processes. Objective This study aims to develop a machine learning-based predictive model for early detection and classification of breast cancer using the Wisconsin Breast Cancer Diagnostic dataset. Methods The dataset, comprising 569 samples and 32 features derived from fine needle aspirate biopsy images, was pre-processed through data cleaning, normalization using the Robust Scaler, and feature selection. Five supervised ML algorithms—Logistic Regression, Support Vector Classification (SVC) with linear and radial basis function (RBF) kernels, Decision Tree, and Random Forest—were implemented. Models were evaluated using performance metrics, including accuracy, precision, sensitivity, specificity, and F1 scores. Results The SVC-RBF model demonstrated the highest accuracy (98.68%) and balanced performance across other metrics, making it the most effective classifier for distinguishing between benign and malignant tumors. Key features such as texture mean and area (worst) significantly contributed to classification accuracy. Conclusions This study highlights the potential of ML algorithms, particularly SVC-RBF, to revolutionize breast cancer diagnostics through improved accuracy and efficiency. Future research should validate these findings with diverse datasets and explore their integration into clinical workflows to enhance decision-making and patient care.

9 May 2026 in F1000Research
Verified
Journal Article
Open access
PDF file
RRRinsy Rahman
Rinsy Rahman
DSDola Saha
Dola Saha
WDWinniecia Dkhar
Winniecia Dkhar
SMSathyendranath Malli
Sathyendranath Malli
NANeil Barnes Abraham
Neil Barnes Abraham
Background Breast cancer remains a significant global health concern, with over 7.8 million cases reported in the last five years. Early detection and accurate classification are crucial for reducing mortality rates and improving outcomes. Machine learning (ML) has emerged as a transformative tool in medical imaging, enabling more efficient and accurate diagnostic processes. Objective This study aims to develop a machine learning-based predictive model for early detection and classification of breast cancer using the Wisconsin Breast Cancer Diagnostic dataset. Methods The dataset, comprising 569 samples and 32 features derived from fine needle aspirate biopsy images, was pre-processed through data cleaning, normalization using the Robust Scaler, and feature selection. Five supervised ML algorithms—Logistic Regression, Support Vector Classification (SVC) with linear and radial basis function (RBF) kernels, Decision Tree, and Random Forest—were implemented. Models were evaluated using performance metrics, including accuracy, precision, sensitivity, specificity, and F1 scores. Results The SVC-RBF model demonstrated the highest accuracy (98.68%) and balanced performance across other metrics, making it the most effective classifier for distinguishing between benign and malignant tumors. Key features such as texture mean and area (worst) significantly contributed to classification accuracy. Conclusions This study highlights the potential of ML algorithms, particularly SVC-RBF, to revolutionize breast cancer diagnostics through improved accuracy and efficiency. Future research should validate these findings with diverse datasets and explore their integration into clinical workflows to enhance decision-making and patient care.

23 June 2026 in F1000Research
Verified
Journal Article
Open access
RRRinsy Rahman
Rinsy Rahman
DSDola Saha
Dola Saha
WDWinniecia Dkhar
Winniecia Dkhar
SMSathyendranath Malli
Sathyendranath Malli
NANeil Barnes Abraham
Neil Barnes Abraham
Background Breast cancer remains a significant global health concern, with over 7.8 million cases reported in the last five years. Early detection and accurate classification are crucial for reducing mortality rates and improving outcomes. Machine learning (ML) has emerged as a transformative tool in medical imaging, enabling more efficient and accurate diagnostic processes. Objective This study aims to develop a machine learning-based predictive model for early detection and classification of breast cancer using the Wisconsin Breast Cancer Diagnostic dataset. Methods The dataset, comprising 569 samples and 33 features derived from fine needle aspirate biopsy images, was pre-processed through data cleaning, normalization using the Robust Scaler, and feature selection. Five supervised ML algorithms—Logistic Regression, Support Vector Classification (SVC) with linear and radial basis function (RBF) kernels, Decision Tree, and Random Forest—were implemented. Models were evaluated using performance metrics, including accuracy, precision, sensitivity, specificity, and F1 scores. Results The SVC-RBF model demonstrated the highest accuracy (98.68%) and balanced performance across other metrics, making it the most effective classifier for distinguishing between benign and malignant tumors. Key features such as texture mean and area (worst) significantly contributed to classification accuracy. Conclusions This study highlights the potential of ML algorithms, particularly SVC-RBF, to revolutionize breast cancer diagnostics through improved accuracy and efficiency. Future research should validate these findings with diverse datasets and explore their integration into clinical workflows to enhance decision-making and patient care.